SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-015247
Filing Date
2024-04-08
Accepted
2024-04-08 16:07:11
Documents
16
Period of Report
2024-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20240408.htm   iXBRL 8-K 31726
2 EX-99.1 a991ex040824.htm EX-99.1 20862
6 crdf-20240408_g1.jpg GRAPHIC 2732
7 image_0.jpg GRAPHIC 143937
  Complete submission text file 0001628280-24-015247.txt   383248

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240408.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240408_lab.xml EX-101.LAB 20770
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240408_pre.xml EX-101.PRE 12001
19 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240408_htm.xml XML 2607
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 24829646
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)